Similarly, our research reveals that an increased level of mitophagy induced by PTPROt suppresses the activation of the ROS-inflammasome-proinflammatory cytokine axis, thereby limiting inflammation in our NASH model. This evidence concerns the gene PTPRO and metabolic dysfunction-associated steatohepatitis.